Literature DB >> 985432

The regulation of folate and methionine metabolism.

H A Krebs, R Hems, B Tyler.   

Abstract

1. The isolated perfused rat liver and suspensions of isolated rat hepatocytes fail to form glucose from histidine, in contrast with the liver in vivo. Both rat liver preparations readily metabolize histidine. The main end product is N-formiminoglutamate. In this respect the liver preparations behave like the liver of cobalamin- or folate-deficient mammals. 2. Additions of L-methionine in physiological concentrations (or of ethionine [2-amino-4-(ethylthio)butyric acid]) promotes the degradation of formiminoglutamate, as is already known to be the case in cobalamin of folate deficiency. Added methionine also promotes glucose formation from histidine. 3. Addition of methionine accelerates the oxidation of formate to bicarbonate by hepatocytes. 4. A feature common to cobalamin-deficient liver and the isolated liver preparations is taken to be a low tissue methionine concentration, to be expected in cobalamin deficiency through a decreased synthesis of methionine and caused in liver preparations by a washing out of amino acids during the handling of the tissue. 5. The available evidence is in accordance with the assumption that methionine does not directly increase the catalytic capacity of formyltetrahydrofolate dehydrogenase; rather, that an increased methionine concentration raises the concentration of S-adenosylmethionine, thus leading to the inhibition of methylenetetrahydrofolate reductase activity [Kutzbach & Stokstad (1967) Biochim. Biophys. Acta 139, 217-220; Kutzbach & Stokstad (1971) Methods Enzymol. 18B, 793-798], that this inhibition causes an increase in the concentration of methylenetetrahydrofolate and the C1 tetrahydrofolate derivatives in equilibrium with methylenetetrahydrofolate, including 10-formyltetrahydrofolate; that the increased concentration of the latter accelerates the formyltetrahydrofolate dehydrogenase reaction, because the normal concentration of the substrate is far below the Km value of the enzyme for the substrate. 6. The findings are relevant to the understanding of the regulation of both folate and methionine metabolism. When the methionine concentration is low, C1 units are preserved by the decreased activity of formyltetrahydrofolate dehydrogenase and are utilized for the synthesis of methionine, purines and pyrimidines. On the other hand when the concentration of methionine, and hence adenosylmethionine, is high and there is a surplus of C1 units as a result of excess of dietary supply, formyltetrahydrofolate dehydrogenase disposes of the excess. When ample dietary supply causes an excess of methionine, which has to be disposed of by degradation, the increased activity of formyltetrahydrofolate dehydrogenase decreases the supply of methyltetrahydrofolate. Thus homocysteine, instead of being remethylated, enters the pathway of degradation via cystathionine. 7. The findings throw light on the biochemical abnormalities associated with cobalamin deficiency (megaloblastic anaemia), especially on the 'methylfolate-trap hypothesis'. This is discussed. 8...

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 985432      PMCID: PMC1163976          DOI: 10.1042/bj1580341

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Rapid separation of isolated hepatocytes or similar tissue fragments for analysis of cell constituents.

Authors:  R Hems; P Lund; H A Krebs
Journal:  Biochem J       Date:  1975-07       Impact factor: 3.857

2.  Effect of pH upon the reaction kinetics of the enzyme-substrate compounds of catalase.

Authors:  B CHANCE
Journal:  J Biol Chem       Date:  1952-02       Impact factor: 5.157

Review 3.  Methionine metabolism in mammals: the biochemical basis for homocystinuria.

Authors:  J D Finkelstein
Journal:  Metabolism       Date:  1974-04       Impact factor: 8.694

4.  The effect of vitamin B12 deficiency on methylfolate metabolism and pteroylpolyglutamate synthesis in human cells.

Authors:  A Lavoie; E Tripp; A V Hoffbrand
Journal:  Clin Sci Mol Med       Date:  1974-12

Review 5.  Formation, functions and regulatory importance of S-adenosyl-L-methionine.

Authors:  J B Lombardini; P Talalay
Journal:  Adv Enzyme Regul       Date:  1970

6.  Ion-exchange chromatography of physiological sulphur amino acids on a highly crosslinked resin.

Authors:  J O Jeppsson; I M Karlsson
Journal:  J Chromatogr       Date:  1972-10-05

7.  Letter: The methylfolate-trap hypothesis.

Authors:  G Tisman; S J Wu; G E Safire; E Rodriguez
Journal:  Lancet       Date:  1975-05-24       Impact factor: 79.321

8.  Folic acid metabolism in vitamin B12-deficient sheep. Effects of injected methionine on methotrexate transport and the activity of enzymes associated with folate metabolism in liver.

Authors:  J M Gawthorne; R M Smith
Journal:  Biochem J       Date:  1974-07       Impact factor: 3.857

9.  Lack of effect of L-methionine ingestion on 14CO2 excretion from L-histidine (imidazole-2-14C) in folic acid and vitamin B12 deficient humans.

Authors:  H B Stahelin; H S Winchell; N Kusubov
Journal:  Blood       Date:  1970-01       Impact factor: 22.113

10.  High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study.

Authors:  M N Berry; D S Friend
Journal:  J Cell Biol       Date:  1969-12       Impact factor: 10.539

View more
  37 in total

1.  Mitochondrial One-Carbon Pathway Supports Cytosolic Folate Integrity in Cancer Cells.

Authors:  Yuxiang Zheng; Ting-Yu Lin; Gina Lee; Marcia N Paddock; Jessica Momb; Zhe Cheng; Qian Li; Dennis L Fei; Benjamin D Stein; Shivan Ramsamooj; Guoan Zhang; John Blenis; Lewis C Cantley
Journal:  Cell       Date:  2018-11-29       Impact factor: 41.582

2.  Altered folate binding protein expression and folate delivery are associated with congenital hydrocephalus in the hydrocephalic Texas rat.

Authors:  Alicia Requena Jimenez; Naila Naz; Jaleel A Miyan
Journal:  J Cereb Blood Flow Metab       Date:  2018-05-25       Impact factor: 6.200

3.  A weak link in metabolism: the metabolic capacity for glycine biosynthesis does not satisfy the need for collagen synthesis.

Authors:  Enrique Meléndez-Hevia; Patricia De Paz-Lugo; Athel Cornish-Bowden; María Luz Cárdenas
Journal:  J Biosci       Date:  2009-12       Impact factor: 1.826

4.  Reaction of formiminoglutamate with liver glutamate dehydrogenase.

Authors:  J Vińa; R Hems; H A Krebs
Journal:  Biochem J       Date:  1978-03-15       Impact factor: 3.857

5.  Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma.

Authors:  Xiao-Qian Chen; Juan-Ru He; Hui-Yun Wang
Journal:  Med Oncol       Date:  2011-10-11       Impact factor: 3.064

6.  Transsulfuration in an adult with hepatic methionine adenosyltransferase deficiency.

Authors:  W A Gahl; I Bernardini; J D Finkelstein; A Tangerman; J J Martin; H J Blom; K D Mullen; S H Mudd
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

7.  Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cells.

Authors:  K J Scanlon; M Kashani-Sabet
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

8.  In vivo kinetics of formate metabolism in folate-deficient and folate-replete rats.

Authors:  Gregory P Morrow; Luke MacMillan; Simon G Lamarre; Sara K Young; Amanda J MacFarlane; Margaret E Brosnan; John T Brosnan
Journal:  J Biol Chem       Date:  2014-12-05       Impact factor: 5.157

9.  10-formyltetrahydrofolate dehydrogenase-induced c-Jun-NH2-kinase pathways diverge at the c-Jun-NH2-kinase substrate level in cells with different p53 status.

Authors:  Sampa Ghose; Natalia V Oleinik; Natalia I Krupenko; Sergey A Krupenko
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

10.  Hepatic bile acid elution by albumin and bile acid content in isolated rat hepatocytes.

Authors:  S Hashimoto; K Uchida; M Hirata
Journal:  Lipids       Date:  1982-03       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.